- Home
- ETON vs NAAS Comparison
ETON vs NAAS Comparison
Compare ETON & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | NAAS |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 35.8M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ETON | NAAS |
|---|---|---|
| Price | $16.27 | $3.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 214.1K | 46.9K |
| Earning Date | 11-06-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,316,000.00 | $21,817,052.00 |
| Revenue This Year | $107.23 | $378.49 |
| Revenue Next Year | $29.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.77 | N/A |
| 52 Week Low | $11.09 | $1.96 |
| 52 Week High | $23.00 | $40.32 |
Technical Indicators
Market Signals| Indicator | ETON | NAAS |
|---|---|---|
| Relative Strength Index (RSI) | 45.11 | 33.32 |
| Support Level | $16.53 | $3.33 |
| Resistance Level | $17.33 | $3.48 |
| Average True Range (ATR) | 0.64 | 0.17 |
| MACD | 0.08 | -0.04 |
| Stochastic Oscillator | 32.91 | 6.86 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.